PacificHealth Laboratories, Inc. Announces Hockey's Anson Carter to Endorse ACCELERADE Sports Drink

WOODBRIDGE, N.J.--(BUSINESS WIRE)--Dec. 2, 2002--PacificHealth Laboratories, Inc., (NASDAQ: PHLI), a leading nutrition technology company, announced today that they have signed an endorsement agreement with professional hockey's Anson Carter to promote the company's ACCELERADE(R) Sports Drink.
ACCELERADE is already the official sports drink of the American Hockey Coaches Association (AHCA).
Carter is currently playing for the Edmonton Oilers and is in his sixth year in the NHL. Last season, Carter registered 28 goals and 32 assists in his second season with the Oilers. The native of Toronto, Ontario was selected in the 10th round of the draft by the Quebec Nordiques (now the Colorado Avalanche) in the 1992 entry draft. Before beginning his NHL career, Carter was a star for the Michigan State Spartans, registering 102 goals and 68 assists for 170 points in 154 games. "ACCELERADE plays a key role in helping me take my game to the next level by helping my body recover quickly, especially after back-to-back games," said Carter.
"Anson Carter is one of hockey's rising stars and we are proud that he has made ACCELERADE his sports drink of choice," said Dr. Robert Portman, President and CEO of PHLI. "We are seeing more professional athletes like Anson who clearly understand the benefits of drinking ACCELERADE during and after competition."
ACCELERADE is the first sports drink engineered to meet all the hydration, energy and nutrition needs of working muscles. Unlike conventional sports drinks, ACCELERADE has the patented 4 to 1 ratio of carbohydrates to protein to speed the movement of carbohydrate into the muscle. ACCELERADE extends endurance by 24% compared to a conventional sports drink and 57% compared to water.

About PacificHealth Laboratories:

PacificHealth Laboratories, Inc., Woodbridge, NJ, was founded in 1995 to develop and commercialize functionally unique nutritional products for sports performance, weight loss and control of Type 2 diabetes. To learn more about ACCELERADE and PacificHealth Laboratories visit or

Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.